Welcome to our dedicated page for Brunswick SEC filings (Ticker: BC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Brunswick Corporation (NYSE: BC) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. These filings provide detailed information on Brunswick’s marine-focused operations, capital structure, and financial reporting practices.
Brunswick uses Form 8-K to report material events such as quarterly earnings releases, tender offers for its senior notes, and redemptions of long-dated debt. For example, the company filed 8-Ks describing the commencement and subsequent increase of a cash tender offer for its 5.100% Senior Notes due 2052, early tender results and pricing, and notices of full and partial redemptions for its 6.500% Senior Notes due 2048 and 6.375% Senior Notes due 2049. Other 8-K filings incorporate quarterly earnings releases and explain the company’s use of non-GAAP financial measures.
Brunswick’s filings also reference its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which contain additional risk factors and detailed financial statements. Forward-looking statement sections in news releases and 8-Ks direct readers to these reports for comprehensive risk disclosures related to economic conditions, supply chain, distribution, Freedom Boat Club’s franchise model, cybersecurity, and other factors.
Debt and listing-related information appears in filings such as Form 25, where the New York Stock Exchange filed a notification of removal from listing and/or registration for Brunswick’s 6.500% Notes due 2048. This type of filing documents the delisting of specific debt securities from an exchange.
On Stock Titan, AI-generated summaries help explain the key points in Brunswick’s 10-Ks, 10-Qs, and 8-Ks, highlighting items such as segment performance, non-GAAP metrics, and capital markets transactions. Real-time updates from EDGAR ensure that new filings, including Form 4 insider transaction reports when available, appear promptly. This makes it easier to understand how Brunswick manages its marine-focused business, reports earnings, and handles its debt securities over time.
MCCLANATHAN JOSEPH W reported acquisition or exercise transactions in this Form 4 filing.
BRUNSWICK CORP director Joseph W. McClanathan received a stock award of 527 shares of common stock. The shares were granted at a reference price of $79.45 per share and are held directly.
After this grant, his direct holdings total 27,562 Brunswick shares, indicating this was a relatively small, routine compensation-related award.
BRUNSWICK CORP director MaryAnn Wright received a grant of 547 shares of Common Stock, valued at $79.45 per share, as of April 30, 2026. These are deferred shares deposited into her director deferred account and will be distributed in preset installments after she ceases being a director. Following this award, her beneficial holdings total 11,125 shares, including 67 shares acquired through dividend reinvestment through March 2026.
BRUNSWICK CORP director David V. Singer reported a compensation grant of common stock and updated holdings. He received 989 shares of common stock as a grant or award at $79.45 per share, bringing his direct holdings to 36,360 shares. He also reports 19,789 shares held indirectly through the Barbara B Singer 2014 Irrevocable Trust. Footnotes note that 415 of the reported shares are deferred shares to be distributed after he ceases being a director, and 168 shares were acquired through dividend reinvestment.
Brunswick Corp director David C. Everitt received a grant of 704 shares of common stock, valued at $79.45 per share. These are deferred shares deposited into his director deferred account and will be automatically distributed in predetermined installments after he ceases serving as a director. Following this award, his beneficial holdings total 38,965 shares, including 241 shares acquired through dividend reinvestments through March 2026.
BRUNSWICK CORP director J. Steven Whisler received a compensation-related stock award rather than making an open-market trade. He was granted 970 shares of common stock at $79.45 per share, credited as deferred shares to his director deferred account and scheduled to be distributed in installments after he leaves the board.
Following this grant, Whisler’s direct beneficial holdings total 98,496 shares, which include 578 shares acquired through dividend reinvestments through March 2026. In addition, 1,000 shares are reported as held indirectly by a family trust associated with the director.
Brunswick Corp director Roger Wood received a grant of 551 shares of Common Stock on April 30, 2026, as a compensation award rather than an open‑market purchase. The shares were valued at $79.45 each and are credited as deferred shares in his director deferred account.
These deferred shares will be automatically distributed in predetermined installments after he ceases serving as a director. Following this grant, Wood beneficially holds 67,673 shares, including 424 shares acquired through dividend reinvestments through March 2026.
Brunswick Corp director Nancy E. Cooper reported a small mix of equity award and share sale. On April 30, she acquired 555 shares of Brunswick common stock as a grant/award acquisition at $79.45 per share. On May 1, she completed an open-market sale of 194 shares at a weighted average price of $79.36, with individual trade prices ranging from $79.35 to $79.40. After these transactions, she directly holds 27,801 shares of Brunswick common stock, indicating that the sale represents only a small portion of her overall position.
BRUNSWICK CORP director Lauren Patricia Flaherty received a stock-based compensation award. She acquired 527 shares of Brunswick common stock on April 30, 2026 as a grant at $79.45 per share. These shares were deposited into her director deferred account and will be distributed in predetermined installments after she ceases serving on the board.
After this grant, her beneficial holdings total 17,594 shares of Brunswick common stock, which includes 108 shares accumulated through dividend reinvestments through March 2026. The filing reflects routine director compensation rather than an open-market purchase or sale.
Brunswick Corp director Reginald Fils-Aimé received a stock award of 566 shares of Common Stock on April 30, 2026. The award is reported at a price of $79.45 per share and is categorized as a grant or other acquisition. After this award, he directly holds 11,451 Brunswick shares.
Nancy E. Cooper submitted a Form 144 notice to sell 194 shares of Common stock. The filing lists prior 10b5-1 sales of 192 shares on 02/19/2026 with an associated amount of $16,826.88. The broker is Morgan Stanley Smith Barney LLC and the filing date shown is 05/01/2026.